Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

Form 8.3 - Maitland Institutional Services Limited: Re Clinigen Group Plc NPV
Form 8.3 - Maitland Institutional Services Limited: Re Clinigen Group Plc NPV
Form 8.3 - Maitland Institutional Services Limited: Re Clinigen Group Plc NPV
Form 8.3 - Maitland Institutional Services Limited: Re Clinigen Group Plc NPV
Form 8.3 - Maitland Institutional Services Limited: Re Clinigen Group Plc NPV
Form 8.3 - Maitland Institutional Services Limited: Re Clinigen Group Plc NPV
Form 8.3 - Maitland Institutional Services Limited: Re Clinigen Group plc
Form 8.3 - Maitland Institutional Services Limited: Re Clinigen Group plc
Form 8.3 - Maitland Institutional Services Limited: Re Clinigen Group plc
Form 8.3 - Maitland Institutional Services Limited: Form 8.3  -  Clinigen Group plc
Form 8.3 - Maitland Institutional Services Limited: Form 8.3 - Clinigen Group plc
Form 8.3 - Maitland Institutional Services Limited: Form 8.3 - Clinigen Group plc
Form 8.3 - Maitland Institutional Services Limited: Re Clinigen Group Plc NPV
Form 8.3 - Maitland Institutional Services Limited: Re Clinigen Group Plc NPV
Form 8.3 - Maitland Institutional Services Limited: Re Clinigen Group Plc NPV
Form 8.3 - Maitland Institutional Services Limited: Re Clinigen Group Plc: Opening Position Disclosure
Form 8.3 - Maitland Institutional Services Limited: Re Clinigen Group Plc: Opening Position Disclosure
Form 8.3 - Maitland Institutional Services Limited: Re Clinigen Group Plc: Opening Position Disclosure
LivaNova to Present Scientific Data on VNS Therapy for Drug-Resistant Epilepsy at American Epilepsy Society 2021 Annual Meeting: https://mms.businesswire.com/media/20191101005329/en/555341/5/LN-Logo-Main-PANTONE.jpg
LivaNova to Present Scientific Data on VNS Therapy for Drug-Resistant Epilepsy at American Epilepsy Society 2021 Annual Meeting


LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced its participation in the American Epilepsy Society (AES) Annual Meeting taking place December

LivaNova to Present Scientific Data on VNS Therapy for Difficult-to-Treat Depression at 4th International Brain Stimulation Conference: https://mms.businesswire.com/media/20191101005329/en/555341/5/LN-Logo-Main-PANTONE.jpg
LivaNova to Present Scientific Data on VNS Therapy for Difficult-to-Treat Depression at 4th International Brain Stimulation Conference


LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced its participation in the 4th International Brain Stimulation Conference, taking place

Positive News is Driving This Cancer Drug Maker’s Stock Higher: https://www.marketbeat.com/logos/articles/med_20240712145036_positive-news-is-driving-this-cancer-drug-makers-s.jpg
Positive News is Driving This Cancer Drug Maker’s Stock Higher

Shares of IDEAYA Biosciences Inc. (NASDAQ: IDYA) are up more than 16% after announcing positive treatment data for its Phase 2 clinical trial. The company’s pipeline candidate, IDE397, is an

What Is a Dividend Cut? An Exploration: https://www.marketbeat.com/logos/articles/med_20240710114043_what-is-a-dividend-cut-an-exploration.jpg
What Is a Dividend Cut? An Exploration

A dividend cut occurs when a company decides to reduce the amount that it pays out in dividends. There are many reasons why a company might do this, including financial hardship, debt reduction, or

Determining Your Risk Tolerance - A Comprehensive Guide: https://www.marketbeat.com/logos/articles/med_20240529082231_determining-your-risk-tolerance---a-comprehensive.jpg
Determining Your Risk Tolerance - A Comprehensive Guide

Risk tolerance varies from person to person. Some people have no fear of parachuting out of an airline, while others won’t even ride a rollercoaster at a theme park. Everyone is a combination of

AstraZeneca: Rebound in 2024 with double-digit earnings growth: https://www.marketbeat.com/logos/articles/med_20240110195346_astrazeneca-rebound-in-2024-with-double-digit-earn.jpg
AstraZeneca: Rebound in 2024 with double-digit earnings growth

U.K.-based AstraZeneca PLC (NASDAQ: AZN) is up 8.95% in the past month as investors grow optimistic about the company's improved earnings outlook for 2024. Not only are sales of cancer and

3 stocks that crushed earnings estimates and still tanked: https://www.marketbeat.com/logos/articles/med_20231119155357_chart-sghc.jpg
3 stocks that crushed earnings estimates and still tanked

Stocks that crush their earnings estimates are supposed to go up. However, that's not always the case. Every earnings season, regardless of sector or industry, has its share of stocks that report

GSK is a remedy for the winter investment blahs: https://www.marketbeat.com/logos/articles/med_20231107083808_chart-gsk-1172023ver001.png
GSK is a remedy for the winter investment blahs

GSK (NYSE: GSK) is not immune to the patent cliff faced by the pharmaceutical industry, but it is about as well prepared as it can be. The company faces a smaller impact than others, has years to

Outcrop Silver & Gold to Present at Precious Metals Summit Zurich: https://www.irw-press.at/prcom/images/messages/2023/72378/OutcropSilver_102523_ENPRcom.001.jpeg
Outcrop Silver & Gold to Present at Precious Metals Summit Zurich

Vancouver, British Columbia--(October 25, 2023) - Outcrop Silver & Gold (TSXV: OCG) (OTCQX: OCGSF) is pleased to announce its participation at the 2023 Precious Metals Summit Zurich where it

Outcrop Silver & Gold nimmt am Precious Metals Summit Zurich teil: https://www.irw-press.at/prcom/images/messages/2023/72378/OutcropSilver_102523_DEPRcom.001.jpeg
Outcrop Silver & Gold nimmt am Precious Metals Summit Zurich teil

 

Vancouver, British Columbia--(25. Oktober 2023) - Outcrop Silver & Gold (TSXV: OCG) (OTCQX: OCGSF) freut sich bekannt zu geben, dass das Unternehmen am Precious Metals Summit Zurich 2023

2 Mega Caps With Comeback Rallies About To Start: https://www.marketbeat.com/logos/articles/med_20231022204145_2-mega-caps-with-comeback-rallies-about-to-start.jpg
2 Mega Caps With Comeback Rallies About To Start

After a stellar first half to the year, especially when compared to last year's bloodbath, the S&P 500 index has been trending down since August. Friday was its third big down day in a row, and by

Does A 7.6% Dividend Make Walgreens A Better Buy Than CVS?: https://www.marketbeat.com/logos/articles/med_20230828140619_does-a-7.jpg
Does A 7.6% Dividend Make Walgreens A Better Buy Than CVS?

Very rarely do investors get the opportunity to consider a purchase of a high-quality asset or company at a steep discount to the overall industry it operates within. Today, there is not only one

5 High-Yielding S&P Stocks: Is It The Right Time To Buy?: https://www.marketbeat.com/logos/articles/med_20230824073050_5-high-yielding-sp-stocks-is-it-the-right-time-to.jpg
5 High-Yielding S&P Stocks: Is It The Right Time To Buy?

About three-fourths of the S&P 500 pay a dividend. According to S&P Dow Jones Indices, dividends have contributed approximately 32% of total S&P return since 1926. 

The current yield of the S&P

Are High-Yielding AT&T And Verizon Worth Buying As Prices Skid?: https://www.marketbeat.com/logos/articles/med_20230817071344_are-high-yielding-att-and-verizon-worth-buying-as.jpg
Are High-Yielding AT&T And Verizon Worth Buying As Prices Skid?

Oh, how the mighty have fallen. Back in the days when people talked of so-called “blue chip” stocks, those that seemingly could do no wrong, America’s telecom stock was AT&T Inc. (NYSE: T)

But

Are foreign investments in Botswana's mining sector still safe?: https://www.irw-press.at/prcom/images/messages/2023/71631/NR-The_Rule_of_law_EN_KB_PRcom.001.jpeg
Are foreign investments in Botswana's mining sector still safe?

Brandenburg, August 14, 2023 - Botswana is one of the most stable and transparent countries in Africa. The government of Botswana is committed to diversifying its economy and securing more

Drinks, Chips & Drugs: A Surprising List of 10-Year Stock Winners: https://www.marketbeat.com/logos/articles/med_20230810075549_drinks-chips-drugs-a-surprising-list-of-10-year-st.jpg
Drinks, Chips & Drugs: A Surprising List of 10-Year Stock Winners

Global financial crises. A pandemic. Recession. Countless geopolitical conflicts.

A lot has happened over the last 10 years. 

The U.S. stock market has been rattled by a range of events and yet

Can the Amazon Partnership Put DISH Network Back on Track?: https://www.marketbeat.com/logos/articles/med_20230731122853_chart-dish2.jpg
Can the Amazon Partnership Put DISH Network Back on Track?

Satellite TV and wireless provider DISH Network Co. (NASDAQ: DISH) stock surged higher on news of a partnership to sell mobile services to Amazon Prime members. DISH is one of the few mainstream

Is AT&T Stock a Golden Opportunity or 'Lead' Weight?: https://www.marketbeat.com/logos/articles/med_20230724142121_is-att-stock-a-golden-opportunity-or-lead-weight.png
Is AT&T Stock a Golden Opportunity or 'Lead' Weight?

AT&T Inc. (NYSE:T) is being haunted by a ghost of telecommunications past. 

Emerging concerns about the lead content of the industry’s legacy cables spooked environmentalists and investors alike

Viasat Drops 29%: Falling Knife or Moonshot Bargain?: https://www.marketbeat.com/logos/articles/med_20230717134826_viasat-drops-29-falling-knife-or-moonshot-bargain.jpg
Viasat Drops 29%: Falling Knife or Moonshot Bargain?

Last month, digital satellite telecommunications pioneer Viasat, Inc. (NASDAQ: VSAT) was on top of the world. The company had just wrapped up a $7.3 billion acquisition of U.K. rival Inmarsat to